全文获取类型
收费全文 | 39272篇 |
免费 | 370篇 |
国内免费 | 302篇 |
专业分类
安全科学 | 1037篇 |
废物处理 | 1580篇 |
环保管理 | 4840篇 |
综合类 | 8698篇 |
基础理论 | 9712篇 |
环境理论 | 13篇 |
污染及防治 | 9591篇 |
评价与监测 | 2324篇 |
社会与环境 | 1921篇 |
灾害及防治 | 228篇 |
出版年
2022年 | 312篇 |
2021年 | 259篇 |
2019年 | 264篇 |
2018年 | 504篇 |
2017年 | 520篇 |
2016年 | 766篇 |
2015年 | 599篇 |
2014年 | 923篇 |
2013年 | 2910篇 |
2012年 | 1086篇 |
2011年 | 1504篇 |
2010年 | 1299篇 |
2009年 | 1401篇 |
2008年 | 1526篇 |
2007年 | 1606篇 |
2006年 | 1384篇 |
2005年 | 1216篇 |
2004年 | 1180篇 |
2003年 | 1172篇 |
2002年 | 1114篇 |
2001年 | 1473篇 |
2000年 | 1048篇 |
1999年 | 652篇 |
1998年 | 442篇 |
1997年 | 486篇 |
1996年 | 495篇 |
1995年 | 574篇 |
1994年 | 563篇 |
1993年 | 482篇 |
1992年 | 491篇 |
1991年 | 506篇 |
1990年 | 534篇 |
1989年 | 501篇 |
1988年 | 400篇 |
1987年 | 396篇 |
1986年 | 386篇 |
1985年 | 378篇 |
1984年 | 389篇 |
1983年 | 384篇 |
1982年 | 383篇 |
1981年 | 386篇 |
1980年 | 322篇 |
1979年 | 363篇 |
1978年 | 280篇 |
1977年 | 284篇 |
1975年 | 249篇 |
1974年 | 260篇 |
1973年 | 280篇 |
1972年 | 248篇 |
1967年 | 276篇 |
排序方式: 共有10000条查询结果,搜索用时 921 毫秒
991.
Dr. Yash P. Agrawal Päivi Ylikangas Markku T. Parviainen Ilkka M. Penttilä 《黑龙江环境通报》1994,14(12):1141-1149
The histochemical measurement of urea-resistant alkaline phosphatase from maternal blood neutrophils is known to have a high detection rate for the prenatal detection of Down's syndrome pregnancies. However, because the histochemical method is laborious and subjective to use, it has not gained widespread acceptance in prenatal screening programmes. We present a simple and objective method for the measurement of urea-resistant alkaline phosphatase by flow cytometry. The method should allow the design of larger studies aimed at evaluating the role of neutrophil urea-resistant alkaline phosphatase in the prenatal screening for Down's syndrome. 相似文献
992.
Ultrasound examination at 12 weeks' gestation revealed severe generalised subcutaneous oedema in a pregnancy at risk for achondrogenesis type II. Transvaginal scanning confirmed the oedema and suggested abnormal limb development. The prenatal diagnosis was confirmed by X-ray examination after transvaginal termination. 相似文献
993.
The value of maternal serum pregnancy-associated plasma protein (PAPP)-A in screening for Down syndrome in early pregnancy was assessed using stored samples. Seventeen cases of Down syndrome and 66 unaffected control pregnancies were studied. The median PAPP-A level in the cases was 0.42 multiples of the expected value in controls (p <0.0001). Eleven cases (65 per cent) had levels less than half the expected value compared with only six controls (9 per cent). A commercial assay kit is now needed so that prospective screening with this marker can begin. 相似文献
994.
Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome. The screened population comprised 15 pregnancies affected by Edward's syndrome, 15 with Down's syndrome and 5472 unaffected pregnancies. The use of all three markers to estimate Edward's syndrome risk would have led to the detection of 10–12 (67–80 per cent) cases with a false-positive rate of 0.3–0.6 per cent depending on the risk cut-off. A further case would have been detected as a result of screening for Down's syndrome alone. Similar results were obtained when the Edward's syndrome risk was based on uE3 and hCG only. These data suggest that extending Down's syndrome screening to include Edward's syndrome risk will yield a high detection rate with only a small increase in the false-positive rate. 相似文献
995.
Andrew D. Dorfmann Jeane Perszyk Patricia Robinson Susan H. Black Joseph D. Schulman 《黑龙江环境通报》1992,12(11):899-902
This paper reports eight cases of non-mosaic, rare, and typically lethal trisomies diagnosed in chorionic villi and not confirmed by amniocentesis. Four cases were 47,XX, + 16; two cases were 47,XX, +2; one was 47,XX, + 12; and one was 47,XY, +7. There have been no known complications in any of these gestations. These eight cases were found in a series of approximately 12 000 samples processed in our laboratory (0.07 per cent). We conclude that (1) rare non-mosaic trisomy not reflecting the fetal condition is an occasional source of diagnostic ambiguity in chorionic villus sampling; and (2) when encountered, a follow-up amniocentesis should be recommended to the patient to confirm or rule out the abnormality. We propose the term ‘confined placental abnormality’ to describe non-mosaic trisomies and other related abnormalities found only in chorionic tissue. 相似文献
996.
E. Keller Dipl.-Biol. A. Andreas S. Scholz H. C. Dörr D. Knorr E. D. Albert 《黑龙江环境通报》1991,11(11):827-840
In 19 pregnancies at risk for 21-hydroxylase deficiency (21OHD) in 18 families with at lea one affected child, prenatal diagnosis was performed by RFLP analysis using the enzymi Taq I and EcoRI and the DNA probes specific for the 21 OH genes, the closely linke complement C4 genes and the highly polymorphic HLA class II genes DRB, DQB, and DPI For fetal DNA analysis either chorionic villi or cultivated amniotic cells were used. In all 1 cases, a clear prenatal diagnosis was possible either with the 21OH probe alone or in mo cases, by combining the results of the different closely linked loci. 相似文献
997.
William D. Boelter MD Beth Ann Burt Elaine B. Spector David R. Hinton Zdena Pavlova Atsuko Fujimoto 《黑龙江环境通报》1990,10(11):703-715
A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated. 相似文献
998.
A. Caruso A. Lanzone V. Bianchi M. Massidda M. P. Castelli A. M. Fulghesu Professor S. Mancuso 《黑龙江环境通报》1987,7(1):41-50
The efficacy of the insulin infusion pump (CSII) in pregnancy was examined in 12 diabetic patients and compared with intermittent insulin therapy (IIT). In patients poorly controlled on IIT constant and rapid equilibrium was achieved with CSII (mean of glucose levels: CSII versus IIT=84 versus 137 mg/dl; S.D. = 36 versus 63 mg/dl; mean amplitude of glycemic excursion (MAGE)=65 versus 112 mg/dl. In patients well controlled on IIT, CSII led to a reduction in the variation of glucose excursions (S.D.= 29 versus 36 mg/dl; MAGE=48 versus 76 mg/dl). CSII generally produced a reduction of 20–37 per cent of daily insulin dose (in three cases there was an increase of dose with the achievement of glycemic control). Furthermore in CSII treated-patients amniotic glucose, insulin and C-peptide concentrations werefound tobeinthenormalrange(22.1±10.1 mg/dl; 5.2±2.7μ/ml; 1.25±0.71 ng/ml, respectively). All infants were horn at or near-term, had no macrosomia or neonatal problems. It is concluded that CSII is a highly efficient way to achieve normal glucose levels in pregnancy, not only in type I, hut also in type II or gestational diabetes. 相似文献
999.
1000.